Alexandria (ARE) Unveils Alexandria LaunchLabs In Cambridge
Zacks Investment Research | Dec 16, 2018 11:47PM ET
Alexandria Real Estate Equities, Inc. (NYSE:ARE) is expanding the company’s full-service life-science start-up platform, Alexandria LaunchLabs, with the opening of its first Cambridge location at the Alexandria Center in One Kendall Square (NYSE:SQ). The move comes as part of the company’s expansion efforts to bank on the life-science real estate industry’s favorable fundamentals.
Particularly, the 20,000-square-foot seed- and early-stage incubator opens with more than 10 innovative seed- and early-stage member companies. There is a high demand for this platform, as well as for its prime location in the heart of East Cambridge's Kendall Square, known as the world's most innovative square mile. This is evident from the strong pool of applicants for this facility.
The company will provide flexible, cost-effective, move-in ready and well-equipped wet laboratory and office space. Further, it would offer high-quality equipment and services, mentorship and programming, in addition to seed-capital access through Alexandria Seed Capital Platform.
Notably, with its prized site at the Alexandria Center for Life Science – New York City and Cambridge location at the Alexandria Center at One Kendall Square, the company remains well poised to provide a solid start-up platform for life-science companies. This, in turn, will spur demand for life-science space over the long run. Given the company’s expertise and robust balance-sheet capacity, it might capitalize well on the same and ride on its growth curve.
Joel S. Marcus, executive chairman and founder of Alexandria Real Estate Equities, Inc. and Alexandria Venture Investments informed, “Our unique, fully integrated Alexandria LaunchLabs platform and our Alexandria Seed Capital Platform will continue to fill the crucial role in aiding transformative seed- and early-stage companies in their efforts to develop novel, cost-effective therapies to ease human suffering."
Moreover, recently the company announced a 4.3% sequential hike in quarterly cash dividend. In November, Alexandria announced that it has commenced development of a 175,000 rentable square feet (RSF) Class A property on its Maryland campus at 9800 Medical Center Drive. The move comes as part of its effort to enhance property base in key locations.
Notably, strong fundamentals of the life-science industry are helping the company’s Class A properties in upscale locations to enjoy high occupancy. Its effort to improve credit profile is also encouraging. Nonetheless, the company’s huge development pipeline exposes it to the risk of rising construction costs.
Alexandria currently carries a Zacks Rank #3 (Hold). Over the past month, shares of the company have inched up 0.3%, outperforming the Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.